DOMA

ProFound Therapeutics, originally launched as Doma Therapeutics by Flagship Pioneering, is a biotechnology company pioneering the discovery of the "expanded proteome." The company utilizes its proprietary ProFoundry Platform to systematically identify and characterize thousands of previously undiscovered proteins encoded by the human genome. By mapping these novel proteins, ProFound aims to uncover new biological pathways and therapeutic targets across a broad range of diseases, including metabolic disorders, oncology, and inflammation. The company's approach leverages advanced proteomics, data science, and high-throughput biology to translate these discoveries into a diverse pipeline of first-in-class medicines.